Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00243932 · ClinicalTrials.gov registry record · Phase 2
Clinical Trial of High Dose CoQ10 in ALS
A Phase 2 study, sponsored by Columbia University.
- Completed
- Registry status
- Phase 2
- Development phase
- 185
- Enrollment target
NCT00243932 is a Phase 2 study that has completed, run by Columbia University. The registered enrollment target is 185 participants.
The verdict
NCT00243932, a Phase 2 study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 185 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the efficacy and preferred dose of CoQ10 in individuals with ALS for a possible future phase III study.
Interventions
- DRUG Placebo
- DRUG coenzyme Q10
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 185 participants |
| Start Date | 2005-04 |
| Est. Completion | 2008-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00243932
The ClinicalTrials.gov registry entry for NCT00243932 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 185 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00243932 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00243932 about?
NCT00243932 is a clinical study titled "Clinical Trial of High Dose CoQ10 in ALS". The purpose of this study is to determine the efficacy and preferred dose of CoQ10 in individuals with ALS for a possible future phase III study.
What is the current status of trial NCT00243932?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 185 participants. The study started on 2005-04. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00243932?
The interventions under investigation include: Placebo (DRUG), coenzyme Q10 (DRUG).
Who is sponsoring clinical trial NCT00243932?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.